About ChitogenX, Inc. 
ChitogenX, Inc.
Pharmaceuticals & Biotechnology
Ortho Regenerative Technologies Inc is a Canada-based biotechnology company. The Company is developing a platform for the repair of tears to soft tissues in joints, and for articular cartilage repair, to restore healthy joint motion and prevent or delay osteoarthritis. The Company's initial focus is in creating new treatments for tears to the meniscus in the knee and the shoulder cuff. The Company's biopolymer has been designed for the healing rates of sports related injuries to ligaments, tendons and cartilage. The polymer can be directly placed into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention.
Company Coordinates 
Company Details
16667 Hymus Blvd , KIRKLAND QC : H9H 4R9
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Dr. Brent Norton
Executive Co-Chairman of the Board, Acting Chief Executive Officer
Mr. Steven Saviuk
Executive Co-Chairman of the Board
Mr. Michael Buschmann
Director
Revenue and Profits:
Net Sales:
(Quarterly Results - Oct 2024)
Net Profit:
-1 Million
Pharmaceuticals & Biotechnology
CAD 0 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.57
28.76%
-0.06






